• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Kids v Cancer

A PEDIATRIC CANCER THINK TANK

DONATE
  • GIVE KIDS A CHANCE act
  • RACE for Children Act
  • Creating Hope Act Pediatric Vouchers
  • CLIMB THE HILL
    • What is Climb the Hill Day?
    • Climb the Hill Youth Advocacy Day Sign Up
    • Video and photo gallery
    • (video) Climb the Hill Youth Advocacy Day — Why Do We Do It?
  • Compassionate Use Navigator
    • Information for Families
    • Information for Physicians
  • Who We Are
    • About Us
    • Mission and Impact
    • Contact
  • News & publications
    • Kids v Cancer in the News
    • Kids v Cancer Publications

Molecular target list for targets NOT requiring a pediatric study plan

The list includes molecular targets for which there is evidence  that indicates that they are not associated with the growth or progression of pediatric tumors, and for which requirement for early pediatric assessment of drugs and biologics directed at these targets could be waived.

The Non-Relevant Molecular Target Leading to Waiver List

For more information, please visit FDA’s Oncology Center of Excellence.

 

  • RACE for Children Act Overview
  • Statutory Text
  • FDA Guidance for Industry
  • Molecular target list
  • Molecular target list for targets NOT requiring a pediatric study plan
  • RACE for Children Act News
  • Nature Editorial Supports RACE
RACE at Curefest
  • Facebook
  • Twitter

DONATE SUBSCRIBE

Kids v Cancer · 3602 Newark Street NW · Washington D.C. 20016 · 646-361-3590 · contact

© 2023 Kids v Cancer · All Rights Reserved a 501(c)(3) nonprofit organization · EIN 27-1427784 · Privacy Policy · Terms of Use · Sitemap